Venom yields from Australian and some other species of snakes
@article{Mirtschin2006VenomYF, title={Venom yields from Australian and some other species of snakes}, author={Peter J. Mirtschin and Nathan Dunstan and Ben Hough and Ewan J. M. Hamilton and Sharna Klein and Jonathan Lucas and David Millar and Frank Madaras and Timothy Nias}, journal={Ecotoxicology}, year={2006}, volume={15}, pages={531-538} }
The wet and dry venom yields for most Australian native dangerous snakes and a number of non-Australian species are presented. Snakes from the Pseudonaja genus yielded higher than previously published amounts and suggest reconsideration be given to increasing the volume of antivenom in each vial. Higher percentage solids were obtained from venoms from the 4 cobra species (Naja) and Pseudechis genus included in this series.
54 Citations
Toxinology of Venoms from Five Australian Lesser Known Elapid Snakes
- BiologyBasic & clinical pharmacology & toxicology
- 2012
It is demonstrated that these understudied Australian elapids have varying pharmacological activity, with notable in vitro neurotoxicity for four of the venoms, and may produce mild to moderate effects following systemic envenoming.
Snake venom: From fieldwork to the clinic
- Biology, MedicineBioEssays : news and reviews in molecular, cellular and developmental biology
- 2011
Snake venoms are recognized here as a grossly under‐explored resource in pharmacological prospecting and must be combined with other disciplines if the full potential of snake venom‐derived medications is to be realized.
Snake evolution and prospecting of snake venom
- Biology
- 2012
This thesis provides evidence for the variable mechanisms of venom gene evolution, which presumably is much more flexible than previously thought, and underscores the potential use of the many different types of snake venom toxins that could be screened for use against human disorders.
Comparative Studies of the Venom of a New Taipan Species, Oxyuranus temporalis, with Other Members of Its Genus
- BiologyToxins
- 2014
The results of this study suggest that the venom of the O. temporalis is highly neurotoxic in vitro and may contain procoagulant toxins, making this snake potentially dangerous to humans.
Anticoagulant activity of black snake (Elapidae_ Pseudechis) venoms_ Mechanisms, potency, and antivenom efficacy
- Biology
- 2020
Varespladib may be a clinically viable treatment for anticoagulant toxicity exerted by this species that is not neutralised by available antivenoms, and is suggested to be a cheaper, first-line treatment option to treat PLA2-rich snake venoms globally.
Clinical Effects and Antivenom Dosing in Brown Snake (Pseudonaja spp.) Envenoming — Australian Snakebite Project (ASP-14)
- MedicinePloS one
- 2012
Accumulating evidence is supported that giving more than one vial of antivenom is unnecessary in brown snake envenoming, and the results of this study support accumulating evidence.
Coagulotoxic effects by brown snake (Pseudonaja) and taipan (Oxyuranus) venoms, and the efficacy of a new antivenom.
- BiologyToxicology in vitro : an international journal published in association with BIBRA
- 2019
Proteomic comparisons of venoms of long-term captive and recently wild-caught Eastern brown snakes (Pseudonaja textilis) indicate venom does not change due to captivity.
- BiologyJournal of proteomics
- 2016
Venom Yield and Toxicities of Six Egyptian Snakes with a Description of a Procedure for Estimating the Amount of Venom Ejected by a Single Snake Bite
- Medicine, Biology
- 2010
There was a correlation between the snake body length and the amount of venom ejected by a single bite or that milked from each snake, and this procedure may be helpful for determining the dose of the specific antivenin.
Anticoagulant toxicity of black snake (Elapidae: Pseudechis) venoms: Potency, mechanisms, and antivenom efficacy.
- BiologyToxicology letters
- 2020
References
SHOWING 1-10 OF 12 REFERENCES
Brown Snakes (Pseudonaja Genus): Venom Yields, Prothrombin Activator Neutralization and Implications Affecting Antivenom Usage
- BiologyAnaesthesia and intensive care
- 1998
Electrophoretic and Western blotting analyses of their venoms showed significantly lower avidity of Brown snake antivenom (BS-AV) for the prothrombin activator (PA) component than for other venom components, including the neurotoxins.
ANTIVENOM DEVELOPMENT IN AUSTRALIA
- Biology
- 2005
Evidence of a new novel antivenom is presented, which shows high efficacy in reversing the hemostatic abnormality caused by brown snake envenomation and is also more efficient at reversing overall toxicity.
Studies on the venom of Oxyuranus microlepidotus.
- BiologyJournal of toxicology. Clinical toxicology
- 1983
The Australian Small-scaled Snake, Oxyuranus microlepidotus, is the world's most venomous snake, with a murine LD50 of 0.01 mg/kg and the injected venom:LD50 ratio is 1730, the highest recorded for any snake.
The quantities of venom injected into prey of different size by Vipera palaestinae in a single bite.
- BiologyThe Journal of experimental zoology
- 1974
The size of the prey does not necessarily influence the amount of venom injected by the snake, and in three snakes the mice received three to ten times more than the rats, while in two snakes there was no difference between the amounts injected into either prey.
The mass of venom injected by two elapidae: the taipan (Oxyuranus scutellatus) and the Australian tiger snake (Notechis scutatus).
- BiologyToxicon : official journal of the International Society on Toxinology
- 1982
Efficacy and Potency of Antivenoms in Neutralizing the Procoagulant Effects of Australian Snake Venoms in Dog and Human Plasma
- MedicineAnaesthesia and intensive care
- 1996
Findings support an increase in the dose of antivenom to be used for the treatment of Tiger and especially Brown Snake envenomation complicated by coagulopathy.
The Efficacy of Antivenom in Prevention of Cardiovascular Depression and Coagulopathy Induced by Brown Snake (Pseudonaja) Species Venom
- Medicine, BiologyAnaesthesia and intensive care
- 1991
The dose of antivenom required to prevent severe cardiovascular depression and coagulopathy induced by Pseudonaja textilis venom was 25 times the current recommended dose for clinical use and a tenfold dose was required to neutralise similar effects induced by pseudonaja affinis venom.